Surface Contamination by Antineoplastic Drugs in Two Oncology Inpatient Units

Marie Palamini, D. Hilliquin, Jean-François Delisle, Audrey Chouinard, J. Bussières
{"title":"Surface Contamination by Antineoplastic Drugs in Two Oncology Inpatient Units","authors":"Marie Palamini, D. Hilliquin, Jean-François Delisle, Audrey Chouinard, J. Bussières","doi":"10.1515/pthp-2019-0017","DOIUrl":null,"url":null,"abstract":"Abstract Background Hazardous drugs pose risks to health care workers. To reduce the risk of occupational exposure for all workers, several protective and monitoring measures have been recommended and implemented over the past two decades. This study was undertaken to describe traces contamination with ten antineoplastic drugs in the oncology care unit of two university hospitals. Methods In this descriptive interrupted time series study, data was collected in two hospitals (a pediatric hospital and an adult hospital) in two consecutive years (12 December 2017 and 27 March 2018, defined as Period 1; 17 April 2019 and 12 June 2019, defined as Period 2). In both Period 1 and Period 2, 36 sites were sampled in each inpatient care unit to explore the contamination of surfaces with hazardous drugs. Results A total of 144 samples from the oncology care unit of the two hospitals were obtained for measurement. Overall, 40 % (58/144) of the sampling sites were positive for at least one hazardous drug. In the pediatric centre, 50 % (18/36) and 36 % (13/36) of the sites sampled in Period 1 and Period 2, respectively, were positive for at least one hazardous drug, whereas in the adult hospital, the percentage of sites that were positive for at least one hazardous drug was 19 % (7/36) in Period 1 and 56 % (20/36) in Period 2. Conclusion The surfaces of inpatient care units sampled in this study were contaminated with antineoplastic drugs, and contamination was present throughout the care units (including structures, furniture, medical equipment, and office equipment). Hospitals’ environmental surveillance programs should encompass inpatient care units.","PeriodicalId":19802,"journal":{"name":"Pharmaceutical Technology in Hospital Pharmacy","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Technology in Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/pthp-2019-0017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Background Hazardous drugs pose risks to health care workers. To reduce the risk of occupational exposure for all workers, several protective and monitoring measures have been recommended and implemented over the past two decades. This study was undertaken to describe traces contamination with ten antineoplastic drugs in the oncology care unit of two university hospitals. Methods In this descriptive interrupted time series study, data was collected in two hospitals (a pediatric hospital and an adult hospital) in two consecutive years (12 December 2017 and 27 March 2018, defined as Period 1; 17 April 2019 and 12 June 2019, defined as Period 2). In both Period 1 and Period 2, 36 sites were sampled in each inpatient care unit to explore the contamination of surfaces with hazardous drugs. Results A total of 144 samples from the oncology care unit of the two hospitals were obtained for measurement. Overall, 40 % (58/144) of the sampling sites were positive for at least one hazardous drug. In the pediatric centre, 50 % (18/36) and 36 % (13/36) of the sites sampled in Period 1 and Period 2, respectively, were positive for at least one hazardous drug, whereas in the adult hospital, the percentage of sites that were positive for at least one hazardous drug was 19 % (7/36) in Period 1 and 56 % (20/36) in Period 2. Conclusion The surfaces of inpatient care units sampled in this study were contaminated with antineoplastic drugs, and contamination was present throughout the care units (including structures, furniture, medical equipment, and office equipment). Hospitals’ environmental surveillance programs should encompass inpatient care units.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
两个肿瘤住院病房抗肿瘤药物表面污染分析
背景危险药物对卫生保健工作者构成风险。为了减少所有工人职业接触的风险,在过去二十年中建议并实施了若干保护和监测措施。本研究的目的是描述两所大学医院肿瘤护理部门的十种抗肿瘤药物的痕量污染。方法在这项描述性中断时间序列研究中,连续两年(2017年12月12日和2018年3月27日)在两家医院(儿科医院和成人医院)收集数据,定义为第一期;2019年4月17日和2019年6月12日(定义为第2期)。在第1期和第2期,在每个住院护理单位取样36个地点,以探索有害药物污染的表面。结果从两所医院肿瘤科共获得144份样本进行测量。总体而言,40%(58/144)的采样点至少对一种有害药物呈阳性。在第一阶段和第二阶段,儿科中心50%(18/36)和36%(13/36)的采样点至少对一种有害药物呈阳性,而在成人医院,至少对一种有害药物呈阳性的采样点百分比在第一阶段为19%(7/36),在第二阶段为56%(20/36)。结论本研究取样的住院护理单元表面被抗肿瘤药物污染,并且污染遍及整个护理单元(包括结构、家具、医疗设备和办公设备)。医院的环境监测项目应包括住院病房。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
7
审稿时长
12 weeks
期刊最新文献
Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL) Physicochemical stability of durvalumab (Imfinzi®) concentrate for solution in original vials after first opening Semi-automatic COVID-19 vaccine preparation for upscaling of vaccination: a descriptive study Assessment of the relevance of osmolality measurement as a criterion for the stability of solutions Use of a liquid chromatography-tandem mass spectrometry method to assess the concentration of epinephrine, norepinephrine, and phenylephrine stored in plastic syringes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1